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mass 40,000-41,000 (40-41K) had been ADP-ribosylated, so 
that in vitro incorporation by PTX of [32P]ADP-ribose into the 
protein was attenuated by 79±9% (n=5; P<O.OI). These 
results strongly indicate that endothelin-1 induces the electro-
physiological responses through a PTX-sensitive GTP-binding 
protein, probably G i or Go. 
Endothelins are released in various stressful conditions such 
as cardiac infarction and congestive heart failure6•24, where sym-
pathetic tone is extensively elevated. Therefore, interaction of 
endothelins with sympathetic neurotransmitters25 may play a 
very important role in both physiological and pathophysiolog-
ical states. Using fJ-adrenoceptor stimulation as an example of 
such conditions, we found that endothelin-l, through the ETA 
receptors, exerts a negative modulatory action by interacting 
with certain ion channels. Our results provide the first direct 
evidence that the ETA receptors mediate hyperpolarization and 
shortening of the action potential duration by inhibiting I Ca and 
stimulating IK (ACh) in adult mammalian heart under physiologi-
cal conditions. The effects are coupled to a PTX-sensitive GTP-
binding protein and the inhibition of cAMP accumulation. These 
ETA-receptor-mediated electrophysiological actions of endo-
thelin-1 may give important insights into our understanding of 
the physiological and pathophysiological regulation of heart 
functions. D 
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THE Hox genes encode transcription factors which mediate the 
formation of the mammalian body plan along the anteroposterior 
and appendicular axesl - 15• Para10gous Hox genes within the separ-
ate linkage groups are closely related with respect to DNA 
sequence and expressionI6,17, suggesting that they could have at 
least partially redundant functions. We showed previously that 
mice homozygous for independent targeted disruptions in the ~ara1-
ogous genes hoxa-3 and hoxd-3 had no defects in common l , • But 
our current analysis of double mutants has revealed strong, dosage-
dependent interactions between these genes. We report here that 
in hoxd-3 - homozygotes the first cervical vertebra, the atlas, is 
homeotically transformed to the adjacent anterior structure. Unex-
pectedly, in double mutants, rather than observing a more extensive 
homeotic transformation, the entire atlas is deleted. These observa-
tions are interpreted in terms of a model in which these Hox genes 
differentially regulate the proliferation rates of the appropriate 
sets of precursor cells. 
The absence of overlapping abnormalities in hoxa-T and 
hoxd-T mutant mice does not imply that these two genes do 
not interact. To investigate such interactions, we generated mice 
that are simultaneously mutant for both genes. Because hoxa-
T and hoxd-T homozygotes usually die shortly after birth 
(hoxa-T /hoxa-T mice from cardiovascular dysfunction and 
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hoxd-T /hoxd-T mice from apparent accidental cervical disloca-
tion as a result of a destabilized craniocervical joint), double 
homozygotes were generated by intercrossing compound hetero-
zygotes. From these intercrosses, 284 full-term progeny were 
produced. Of these, 14 were double homozygotes, very close to 
the expected frequency of 1/16, indicating that such mice do not 
die during embryogenesis. 
Figure 1 shows lateral views of skeleton preparations of wild-
type mice, hoxa-T homozygotes, hoxd-T homozygotes and 
double mutants. The craniocervical joint of hoxa-T homo-
zygotes is indistinguishable from that of wild-type animals (com-
pare Fig. 1a and b). The hoxd-3 mutation alone results in a 
remodelling of the bones in the craniocervical joint. In these 
mice, the anterior arch of the atlas forms an extension of the 
basioccipital bone, the atlas lateral masses are remodelled to 
resemble and are often fused to the exoccipitals, the axis is 
remodelled to resemble the atlas, the dens and the superior facets 
of the axis are deleted and the lateral foramina normally associ-
ated with the atlas are now attached to the axis (Fig. Ie and ref. 
8). The double mutant mouse, however, shows a more severe 
phenotype. The entire atlas has been deleted, and only a small 
piece of cartilage remains in its place (Fig. ld). This deletion of 
FIG. 2 The deletion of the atlas depends on the dosage of Hoxa-3 ~ 
mutant alleles in the hoxd-3- homozygote. Lateral views of cleared 
skeleton preparations of newborn mice. a, The craniocervical region in 
a Wild-type newborn (a3+/+; d3+/+). The atlas (at) and axis (ax) are 
indicated. The arrow indicates the ossification centre in the anterior arch 
of the atlas. b, Same view of a hoxd-3 heterozygote (a3+/+; d3+ /-). c, 
The atlas is further altered in this compound heterozygote (a3+ /-; 
d3+/-). The ossification centre in the anterior arch of the 
atlas has failed to form (arrow). d, A hoxd-3 homozygote (a3+/+; 
d3- / -) with a nearly cornplete homeotic transformation of the atlas. 
This is an example of the most extreme hoxd-3 phenotype. e, Compared 
with the hoxd-T homozygote, the atlas is more severely affected in 
the (hoxa-3+/hoxa-T; hoxd-T/hoxd-T) mouse. f, A double-mutant 
newborn (a3-/-; d3-/-). The atlas is deleted and cartilaginous 
fusions between the neural arches of the axis and other cervical verteb-
rae are indicated (arrow). Scale bar, 1.0 mm. 
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FIG. 1 Additional skeletal defects in (hoxa-T/hoxa-T; hoxd-T/ hoxd-
3 - ) mice. Lateral views of cleared skeleton preparations of newborn 
mice. a, A wild-type (a3+/+ ; d3+/+) newborn, the first cervical vertebra 
or atlas (at) and the second cervical vertebra or axis (ax) are labelled. 
b, A Hoxa-3 homozygote (a3-/ -; d3+/+ ). c, A Hoxd-3 homozygote 
(a3+/ + ; d3-/ - ) displaying the characteristic homeotic transformation 
of the atlas (at). d, A hoxa-3, hoxd-3 double homozygote (a3-/-; 
d3- / -) showing the complete absence of the atlas and remodelling of 
the axis (ax). Scale bar, 1 mm. 
METHODS. Newborn skeleton preparations were made as described21 . 
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FIG. 3 The pattern of the cartilage condensations in E13 embryos. a-c, 
Lateral views of cleared preparations of mouse embryos. a, A wild-type 
embryo (a3+/+ ; d3+/+ ). The cartilage anlagen of the basioccipital 
(bo), exoccipital (ex), atlas (at), axis (ax) and dens (d) are indicated. 
b, A hoxd-3 homozygous embryo (a3+/+; d3-/-). c, A double-mutant 
embryo (a3-/-; d3-/-). The atlas is deleted and the cartilage anlage 
of the axis is indicated. d-f, Midsagittal thick sections (100 11m) of the 
embryos pictured in a--c. d, The wild-type embryo (a3+/+; d3+/+), the 
cartilage anlagen for the basioccipital (bo), atlas (at) and axis (ax) are 
indicated. e, The hoxd-3 homozygote (a3+/+; d3-/-) . f, The double-
mutant embryo (a3-/ -; d3-/ -). The assignment of the cervical verte-
brae anlagen in wild-type and mutant mice was confirmed by counting 
rostrally from the first thoracic vertebra anlage. Scale bar, 0.5 mm. 
METHODS. Embryos were collected on embryonic day 13 (morning of 
the plug is 0.5 days), stained with Alcian blue and cleared as 
described22. Stained embryos were removed from benzyl benzoate/ 
benzyl alcohol into methanol, rehydrated in PBS, embedded in 3% 
agarose and sectioned at lOOl1m on a vibratome. Sections were 
dried onto gelatin subbed slides, counterstained with nuclear Fast red 
and mounted in 90% glycerol/PBS. 
FIG. 4 The Hoxa-T defects are more severe in (hoxa-T/ hoxa-3- ; hoxd-
3 -/ hoxd-3 -' ) mice. Lateral views of skeleton preparations of newborn 
mice. a, The laryngeal cartilages in a wild-type (a3+/+; d3+/ +) new-
born mouse. The hyoid bone (hy), thyroid (thy) and cricoid (crc) cartilages 
are indicated. b, The laryngeal cartilages of a hoxa-3 (a3-/-; d3+/ +) 
mutant. The arrow indicates the inferior horn of the thyroid cartilage. 
c, Lateral view of a double homozygote (a3 - /-; d3-/-). Remodelling 
has changed the appearance of the hyoid and thyroid cartilages. The 
dorsal side of the thyroid cartilage (left side) is altered because of the 
deletion of cartilage and the inferior horn of the thyroid cartilage is 
missing (arrow). Scale bar, 0.5 mm. 
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the atlas was observed in all six of the double mutant skeletons 
examined. The axis has also been remodelled to appear more 
like a 'generic' cervical vertebra. 
We reported previously8 that at low penetrance, mice hetero-
zygous for the hoxd-T mutation have mild abnormalities in the 
craniocervical joint (Fig .. 2b). The anterior arch of the atlas is 
reduced in size and has small, unilateral fusions with the basi-
occipital bone. These results suggested that the dosage of the 
hoxd-3 protein is an important factor in determining the severity 
of the abnormalities, and raised the possibility that the inter-
actions between hoxa-3 and hoxd-3 might also be quantitative 
(that is, dosage-dependent). Figure 2 shows that the severity 
of the craniocervical joint abnormality indeed increases as the 
number of wild-type copies of hoxa-3 and hoxd-T decreases. 
Compound heterozygotes (hoxa-T / hoxa-Y; hoxd-T / hoxd-3+) 
show a more severe mutant phenotype at higher penetrance (45% 
versus 15%) than mice heterozygous for the hoxd-T mutation 
alone (compare Fig. 2b and c). The anterior arch of the atlas is 
more reduced and the atlas lateral masses are more extensively 
remodelled than in hoxd-T /hoxd-3+ mice; also note the absence 
of the lateral foramina. In addition, whereas the hoxd-T hetero-
zygotes always have a dens, in the most strongly affected com-
pound heterozygotes the dens is deleted. Furthermore, (hoxa-
T / hoxa-3+; hoxd-T / hoxd-T) mice have a phenotype interme-
diate between that of the (hoxa-3+ /hoxa-3+; hoxd-T /hoxd-T) 
and (hoxa-T / hoxa-T; hoxd-T / hoxd-T) mice (Fig. 2d-f). 
Parts of the atlas are progressively deleted as one and then two 
wild-type copies of hoxa-3 are removed from the hoxd-T homo-
zygous mutant background. 
The bones of the vertebral column are formed by the endo-
chondral pathway in which a cartilaginous prototype is laid 
down before bone formation. The effect of the hoxd-T and 
hoxa-3- mutations can be seen as the precartilaginous condensa-
tions are formed. Figure 3a shows a lateral view of an E13 wild-
type embryo stained to reveal the cartilage anlagen. Figure 3d 
shows a sagittal section of the same embryo counterstained with 
nuclear fast red. The precartilaginous condensations that give 
rise to the basioccipital, the exoccipitals, the atlas, the axis and 
the dens are evident. In the hoxd-T homozygotes (Fig. 3b, e), 
the cartilage anlage that would form the atlas is shifted towards 
the base of the skull and fused along its ventral aspects with the 
basioccipital anlage (Fig. 3e). The shape of the axis anlage has 
changed to resemble more closely the atlas anlage and the dens 
anlage is severely reduced or absent. In the double mutant (Fig. 
3c, f), only a vestige of the atlas anlage remains ventral to the 
notocord. Thus, the change of the hoxd-3 phenotype in the dou-
ble mutants is evident at this embryonic stage. 
Figure 4 shows that the hoxa-3 mutant phenotype is similarly 
exacerbated in mice also mutant for hoxd-3. In hoxa-3 mutants, 
the lesser horns of the hyoid bone are reduced or missing and 
the greater hom of the hyoid is fused with the superior hom of 
the thyroid cartilage (Fig. 4b). In hoxd-T homozygotes these 
elements are not affected8. In the double mutant, the hyoid is 
reduced in size and fuses closer to the body of the thyroid cartil-
age (Fig. 4c). In addition to these changes, cartilage is missing 
dorsally, creating gaps and holes in the lamina of the thyroid 
cartilage. Also, the inferior horns of the thyroid cartilage are 
deleted. These deletions reduce the size of the thyroid cartilage 
and give it a very different appearance from those of the wild-
type and hoxa-T homozygous mutants (Fig. 4a-c). The exacer-
bation of the hoxa-3 phenotype by the hoxd-T mutation is also 
dosage-dependent. For example, although neither hoxa-3 and 
hoxd-3 heterozygotes nor hoxd-3 homozygotes show defects in 
the hyoid/thyroid cartilages, compound heterozygotes (hoxa-
T /hoxa-3+: hoxd-T /hoxd-3+) exhibit fusions between the 
hyoid and thyroid cartilages (data not shown). 
Not all of the hoxa-T phenotypes are exacerbated by the 
hoxd-T mutation. For example, the defects of the heart and its 
great vessels are the same in hoxa-3- homozygotes and in the 
double mutants. Also, the extent of truncation of the soft palate 
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and the reduction in the thyroid and submaxillary glands in 
hoxa-T / hoxa-T and (hoxa-T / hoxa-T; hoxd-T / hoxd-T) 
mice appear to be the same. In contrast some hoxa-3- homozyg-
otes have remnants of a thymus, whereas all double mutants are 
athymic. Also, the phenotype of the epiglottis in double mutants 
is more severe than in hoxa-3- homozygotes. 
Analysis of mice with mutations in both hoxa-3 and hoxd-3 
has revealed strong genetic interactions between these two genes. 
The double-mutant mice have more severe abnormalities than 
predicted from the sum of the individual mutant phenotypes. In 
the double mutants the entire atlas was deleted rather than being 
more extensively transformed into the adjacent anterior bones. 
The extent of deletion of the atlas in hoxd-T /hoxd-T mice 
increased progressively with the loss of one and then two copies 
of the wild-type hoxa-3 gene. The deletion of the atlas precursors 
could be detected in E13 embryos, indicating that the defects 
seen in the newborn animals reflect changes in the early pattern-
ing of the cartilage anlagen for these bones. 
To explain the observation that in hoxd-T /hoxd-T mice parts 
of the atlas and axis were homeotically transformed to resemble 
more anterior structures, whereas other parts were deleted, we 
suggested a model whereby the hoxd-3 product differentially 
regulates the rate of proliferation of precursor cells8. Our finding 
that the entire atlas is deieted in the double mutant lends support 
to this model. In mice carrying both mutations, we propose that 
all of the precursor cells responsible for the formation of the 
atlas fail to proliferate, and thus cannot form the atlas. 
In the context of this model, note that hoxb-8 is transcription-
ally activated in mouse myeloid leukaemia WEHI-3B cells, and 
that transfection of this gene into NIH-3T3 cells produces fibro-
sarcomas in nude mice l8 • Thus, at least some Hox genes can 
function as oncogenes, and are implicated in controlling cell 
proliferation. Similarly, the sets of limb defects resulting from 
targeted disruption of hoxa-ll, hoxd-ll and hoxd-13 are more 
readily interpreted in terms of localized perturbations of the 
growth of cells, than in terms of specification of digit 
identi ty lo,II,15. Furthermore, the metameric hindbrain pattern is 
perturbed in hoxa-r /hoxa-r mice6,7,19. In these mutants, rhom-
bomere 5 is missing and the integrity of rhombomeres 4-7 is 
compromised. These results are also readily interpreted in terms 
of a role for hoxa-l in mediating cell proliferation within the 
neural tube, Postulating roles for Hox genes in regulating proli-
feration of precursor cells is conceptually quite different from 
postulating a role in the specification of cell identity, The former 
may be less complex than the latter and might not require a 
complex 'Hox-code,20. However, these roles are not mutually 
exclusive. 
Alternatively, the deletion of the atlas in the double mutants 
could be explained by increased programmed cell death. How-
ever, careful histological examination of E9,O to E13.0 embryos 
has not revealed an excess of pycnotic cells in the double mutants 
relative to normal controls during the formation of the cranio-
cervical joint anlage. 
It is curious that mice homozygous for either the hoxa-T or 
hoxd-T mutation show no overlap in phenotype. However, the 
double-mutant phenotype demonstrates that these two gene pro-
ducts are cofunctional in many cells. Each gene appears to have 
a primary role during development, but also plays multiple roles 
in combination with other Hox genes. Further, the observed 
progression of both the hoxd-3 and the hoxa-3 mutant pheno-
types as one or two copies of the paralogous genes are removed, 
argues that in normal animals, development is exquisitely sensi-
tive to small changes in the concentration of their respective 
gene products. 0 
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CYCLIC ADP-ribose (cADPR) is a newly identified nucIeotidet,2 
which can release calcium from a variety of cells3-<'i, suggesting it 
is a messenger for mobilizing internal Ca2 + stores. Its cyclic struc-
ture has now been confirmed by X-ray crystallography7. Available 
results are consistent with it being a modulator of Ca2 + -induced 
Ca2+ releaseS-to. Here we report that sea urchin egg microsomes 
purified by Percoll gradients lose sensitivity to cADPR, but the 
response can be restored by a soluble protein in the supernatant. 
Purification and characterization of the protein indicate that it is 
calmodulin. It appears to be sensitizing the Ca2 + release mecha-
nism because caffeine and strontium, agonists of Ca2+ -induced 
Ca2+ release, can also mimic calmodulin in conferring cADPR-
sensitivity. Although evidence indicates that cADPR may be an 
activator of the ryanodine receptorS-tO, present results point to the 
importance of accessory proteins such as calmodulin in modulating 
its activity. 
During the initial investigations on the Ca2+ -mobilizing activi-
ties of cADPR, we noted the requirement of a soluble protein 
factor I . Sea urchin egg microsomes purified by Percoll density 
gradient centrifugation I , II lost the sensitivity to cADPR and did 
not release Ca2 + even when challenged by a saturating concen-
tration of cADPR (Fig. la) The loss could be prevented by 
incubation with the supernatant obtained from the Percoll gradi-
ents . The concentration-dependency of preventing the loss of 
cADPR sensitivity by the supernatant is shown in the inset of 
Fig.la. 
The cADPR-sensitivity-conferring factor is highly conserved 
because soluble extracts from dog brain can also substitute. 
FIG. 1 Requirement of a soluble protein for cADPR-dependent Ca2 + 
release. a, Egg microsomes were incubated with (+Sup) or without 
(-Sup) the factor isolated from supernatants of egg homogenates. Ca2 + 
release was monitored by Fluo 3 (1-2 ilM) and the fluorescence 
changes were calibrated by known amounts of Ca'+ as previously 
described9 . The inset shows the concentration dependency of the 
soluble factor in reconstituting cADPR-sensitive Ca2 + release. b, A par-
tially purified protein from brain can also confer cADPR sensitivity on 
egg microsomes in a concentration-dependent fashion. The inset shows 























~ ~ 1.6 
'0 a c 1.2 
~ ~ 1 ~0.8 
_ 0.4 
"" 
LETTERS TO NATURE 
• 
• • 
~ o~~~ __ ~~~~ 
o 0.2 0.4 0.6 0.8 1.0 1.2 






















Factor from brain extract (/-lg ml- l ) 
• 
12'0~ 3 0 .• ~ 
o " 
150 
fractionation of brain extracts on a DEAE 40 HR column. Elution was 
followed by absorbance at 280 nm (A). The cADPR-sensitivity-conferring 
activity of each fraction was assayed by incubating egg microsomes 
(0.4 ml) with various fractions (40 ill) for 2-3 h at 17°C and then chal-
lenging with 1.25 ~M cADPR. The shaded area in the elution profile 
(inset) indicates the active fractions that were used to construct the 
concentration-response curve. 
METHODS. S. purpuratus eggs were homogenized by nitrogen decavita-
tion and the microsomes purified by Percoll density centrifugation as 
previously described". The soluble fraction (Sup) was prepared by 
centrifuging the Percoll supernatants at 227,OOOg for 30 min at 4°C. 
The microsDmes were diluted 4-5-fold and incubated for about 3 h at 
17 °C in a medium described previouslyl1. The soluble extracts of frozen 
dog brains (Pel Freeze, Rogers, AR) were prepared by homogenization 
(25% w/v) in a buffer containing 0.34 M glucose, 1 mM MgCI2 and 
20 mM HEPES, pH 7.2, 10 ~g ml- 1 leupeptin , 10 ~g ml- 1 aprotinin and 
50 ~g ml- 1 soybean trypsin inhibitor. Homogenization was first with a 
Tissumizer (Tecmar, OH) for 5 s and then 4 strokes with a Dounce glass 
homogenizer. The homogenates were centrifuged at 4 °C for 45 min at 
300,OOOg. The supernatant (50 ml) was loaded onto a 25 x 95 mm 
DEAE 40 HR column (Waters, MA) and eluted with a potassium-acetate 
gradient prepared in 1 mM MgCI" 10 mM HEPES, pH 7.2, as shown in 
the inset of b. Active fractions were combined and further purified on 
a DEAE 5PW and a 300SW gel-filtration column (Waters). Starting with 
333 mg soluble extract about 1.5 mg purified factor was obtained. The 
purification was 89-fold and the yield was 40%. The active factor in egg 
supernatants (Sup) was similarly purified on DEAE 5PW and 300SW gel-
filtration columns. 
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